A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results